Johnson Health Tech .Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 8,028.79 million compared to TWD 7,217.09 million a year ago. Net income was TWD 223.18 million compared to net loss of TWD 507.31 million a year ago. Basic earnings per share from continuing operations was TWD 0.74 compared to basic loss per share from continuing operations of TWD 1.67 a year ago. Diluted earnings per share from continuing operations was TWD 0.74 compared to diluted loss per share from continuing operations of TWD 1.67 a year ago.
For the nine months, sales was TWD 22,122.52 million compared to TWD 21,038.39 million a year ago. Net loss was TWD 105.08 million compared to TWD 436.36 million a year ago. Basic loss per share from continuing operations was TWD 0.35 compared to TWD 1.44 a year ago. Diluted loss per share from continuing operations was TWD 0.35 compared to TWD 1.44 a year ago.